Holen Sie sich die Stockscreener-App
2.96
3.14%
0.09
Handel nachbörslich:
2.95
-0.010
-0.34%
Schlusskurs vom Vortag:
$2.87
Offen:
$2.8
24-Stunden-Volumen:
67,232
Relative Volume:
1.20
Marktkapitalisierung:
$7.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.56M
KGV:
-0.3043
EPS:
-9.7281
Netto-Cashflow:
$-12.24M
1W Leistung:
-1.99%
1M Leistung:
+0.34%
6M Leistung:
-71.11%
1J Leistung:
-56.16%
1-Tages-Spanne:
$2.76
$2.99
1-Wochen-Bereich:
$2.72
$3.135
52-Wochen-Spanne:
$1.76
$19.63
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
2.96 | 7.63M | 0 | -13.56M | -12.24M | -9.7281 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Institution Moves: Is Processa Pharmaceuticals Inc impacted by rising rates2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Market Recap: What are the risks of holding Processa Pharmaceuticals IncMarket Activity Recap & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Nasdaq Moves: Will Processa Pharmaceuticals Inc benefit from current market trendsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn
Weekly Recap: What is the implied volatility of Processa Pharmaceuticals Inc2026 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn
Market Outlook: Is Processa Pharmaceuticals Inc forming higher highs and higher lows2026 Performance Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Whale Trades: Is Processa Pharmaceuticals Inc impacted by rising ratesGDP Growth & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Heatwurx (NASDAQ:PCSA) versus Aquestive Therapeutics (NASDAQ:AQST) Critical Review - Defense World
Insider Buying: James Neal Acquires Shares of Processa Pharmaceu - GuruFocus
Processa Pharmaceuticals Insiders Increase Stock Holdings - Intellectia AI
Director Neal James R adds Processa (PCSA) shares in open trade - Stock Titan
Processa Pharma chief business officer Lin buys $4063 in PCSA By Investing.com - Investing.com India
Insider Buying: Russell Skibsted Acquires Shares of Processa Pha - GuruFocus
Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 - Investing.com UK
Russell Skibsted, CFO, buys Processa Pharma (PCSA) shares worth $5,891 By Investing.com - za.investing.com
Young David, processa pharma pres, buys PCSA shares worth $4588 - Investing.com
Processa Pharma director Pannu buys $5,252 in PCSA stock - Investing.com UK
Processa Pharma director Pannu buys $5,252 in PCSA stock By Investing.com - Investing.com Australia
Young David, processa pharma pres, buys PCSA shares worth $4588 By Investing.com - Investing.com Canada
Ng George K, Processa Pharma CEO, buys PCSA stock worth $5414 - Investing.com Canada
Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 By Investing.com - Investing.com South Africa
Processa Pharmaceuticals (PCSA) R&D head adds 1,810 shares in open-market buy - Stock Titan
Processa Pharmaceuticals (NASDAQ: PCSA) CFO buys 2,324 company shares - Stock Titan
Director Geraldine Pannu buys 2,072 Processa (PCSA) shares in market - Stock Titan
[Form 4] Processa Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Baluch Khoso buys Processa Pharmaceuticals (PCSA) shares worth $5751 - Investing.com
Processa Pharmaceuticals (PCSA) officer adds 1,603-share open-market buy - Stock Titan
Processa Pharmaceuticals (PCSA) CAO buys 1,854 shares in open trade - Stock Titan
Processa (NASDAQ: PCSA) CDO buys 2,107 shares in open-market trade - Stock Titan
Director adds 2,269 Processa (PCSA) shares at $2.535 each - Stock Titan
Processa Pharmaceuticals, Inc.Common Stock (NQ: PCSA - The Chronicle-Journal
Weekly Earnings: Should I hold or sell Processa Pharmaceuticals Inc now2026 Volume & Verified Chart Pattern Trade Signals - baoquankhu1.vn
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Aug PreEarnings: What is Processa Pharmaceuticals Incs valuation compared to sector2026 Trading Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
PCSA PE Ratio & Valuation, Is PCSA Overvalued - Intellectia AI
Trading Recap: Does Processa Pharmaceuticals Inc have a sustainable dividend2026 Final Week & Growth Focused Stock Pick Reports - baoquankhu1.vn
Earnings Recap: Does Processa Pharmaceuticals Inc have strong fundamentalsRate Hike & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in Processa Pharmaceuticals Inc (PCSA) - Stock Titan
Processa Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings - marketscreener.com
Aug Macro: Can Processa Pharmaceuticals Inc maintain sales growthMarket Growth Summary & Daily Price Action Insights - baoquankhu1.vn
Processa Pharmaceuticals Inc: Fundamental Analysis and Financial Ratings - marketscreener.com
Analyst Calls: What are the risks of holding Processa Pharmaceuticals Inc2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Processa Pharmaceuticals 2025 Annual Report: Next Generation Cancer Therapies, Regulatory Strategy, Pipeline, and Intellectual Property Overview - Minichart
Processa Pharmaceuticals 2025 10-K: $0 revenue, $(10.36) EPS on $(13.56)M net loss - TradingView
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
[10-K] Processa Pharmaceuticals, I... - Stock Titan
Processa Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Processa Pharmaceuticals Inc expected to post a loss of $1.50 a shareEarnings Preview - tradingview.com
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Gardner News
Growth Recap: Whats Processa Pharmaceuticals Incs historical return2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):